Resvita Bio Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 9

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 11

Resvita Bio General Information

Description

Developer of a synthetic biology platform intended to create innovative treatments for skin diseases. The company uses genetically engineered bacteria to produce and deliver therapeutic proteins directly to affected areas, with continuous treatment without the limitations of traditional therapies, enabling patients to target conditions such as Netherton Syndrome and Severe Atopic Dermatitis, offering a potentially transformative method for managing skin disorders.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2625 Durant Avenue
  • Berkeley, CA 94720
  • United States
Primary Industry
Discovery Tools (Healthcare)
Vertical(s)
Corporate Office
  • 2625 Durant Avenue
  • Berkeley, CA 94720
  • United States

Resvita Bio Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Resvita Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Accelerator/Incubator 01-Jan-2025 Completed Generating Revenue
7. Grant 24-Sep-2024 Completed Generating Revenue
6. Seed Round 06-Dec-2023 Completed Generating Revenue
5. Grant 01-Jul-2023 Completed Generating Revenue
4. Grant 20-Sep-2022 Completed Generating Revenue
3. Seed Round 06-May-2022 Completed Generating Revenue
2. Accelerator/Incubator Completed Startup
1. University Spin-Out 01-Jan-2021 Completed Startup
To view Resvita Bio’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Resvita Bio Patents

Resvita Bio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4719461-A1 Methods of treating skin conditions using genetically engineered microorganisms Pending 25-May-2023
WO-2024243532-A1 Methods of treating skin conditions using genetically engineered microorganisms Inactive 25-May-2023

Resvita Bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Resvita Bio Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
California Life Sciences Accelerator/Incubator
Berkeley Frontier Fund Venture Capital Minority
California Innovation Fund Venture Capital Minority
Gaingels Venture Capital Minority
Angel (individual) Minority
You’re viewing 5 of 11 investors. Get the full list »

Resvita Bio FAQs

  • When was Resvita Bio founded?

    Resvita Bio was founded in 2021.

  • Where is Resvita Bio headquartered?

    Resvita Bio is headquartered in Berkeley, CA.

  • What is the size of Resvita Bio?

    Resvita Bio has 9 total employees.

  • What industry is Resvita Bio in?

    Resvita Bio’s primary industry is Discovery Tools (Healthcare).

  • Is Resvita Bio a private or public company?

    Resvita Bio is a Private company.

  • What is Resvita Bio’s current revenue?

    The current revenue for Resvita Bio is .

  • Who are Resvita Bio’s investors?

    California Life Sciences, Berkeley Frontier Fund, California Innovation Fund, Gaingels, and are 5 of 11 investors who have invested in Resvita Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process